An act to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment.
HOUSE REPORTS: No. 115-354 (Comm. on Energy and Commerce) accompanying H.R. 2410. CONGRESSIONAL RECORD, Vol. 164 (2018): Oct. 11, considered and passed Senate. Dec. 11, considered and passed House.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
Office of the Federal Register, National Archives and Records Administration. "Public Law 115 - 327 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018". Government. U.S. Government Publishing Office, December 18, 2018. https://www.govinfo.gov/app/details/PLAW-115publ327
APA
Office of the Federal Register, National Archives and Records Administration. (2018, December 18). Public Law 115 - 327 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018. [Government]. U.S. Government Publishing Office. https://www.govinfo.gov/app/details/PLAW-115publ327
MLA
Office of the Federal Register, National Archives and Records Administration. Public Law 115 - 327 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018. U.S. Government Publishing Office, (18 Dec 2018), https://www.govinfo.gov/app/details/PLAW-115publ327
Bluebook
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018, Pub. L. No. 115-327 (2018), https://www.govinfo.gov/app/details/PLAW-115publ327
